The Stereochemical Challenge of Hidden Peptide Impurities: Peptides Revisited
Part V: Peptides Revisited
In the previous article, we brought together the analytical challenges explored throughout this series. We began with hidden stereochemical impurities in amino acid starting materials, followed those impurities into peptide fragments, examined cases where molecular weight alone could not establish amino acid identity, and ultimately considered how these different analytical questions could be addressed within a more comprehensive workflow.
At the time, it seemed like a natural place to end the story. But analytical development rarely stops when the first question has been answered.
Earlier in this series, we explored whether subtle stereochemical differences could still be recognized once amino acids became incorporated into short peptides. Those experiments demonstrated that peptide formation does not necessarily make stereochemical impurities analytically invisible. In the months that followed, we continued pushing that question.
Could the same type of chromatographic recognition extend to a longer peptide? Could it recognize a single stereochemical inversion within a seven amino acid sequence? What if the amino acids remained exactly the same, but their positions changed? What if one residue disappeared entirely?
At that point, the question was no longer simply whether peptide stereoisomers could be separated. The question became: how much molecular change can chromatography actually recognize?
When Peptide Impurities Look Nearly Identical
Peptide impurities are not always dramatically different molecules. During synthesis, purification, and storage, structurally related variants can be produced that differ only subtly from the intended peptide. A single amino acid may adopt the opposite stereochemical configuration, a residue may be deleted or unintentionally inserted, or the sequence order altered while the overall composition remains unchanged1. These variants can be particularly challenging because much of the molecule remains identical to the intended product, and points of differential can become masked by the overall size of the peptide.
Consider an especially difficult case: two peptides with the same molecular weight, the same amino acid composition, the same calculated isoelectric point, and the same calculated global hydrophobicity, only differing by the sequence order. Are they analytically the same molecule? Of course not!
Changing the order of the amino acids doesn’t just change their position within the peptide, it also changes the molecular environment presented to an analytical system. Similarly, replacing a single L-amino acid with its D-form leaves the molecular weight and composition unchanged while altering the stereochemical structure of the peptide.
This creates a familiar analytical problem at a new level of complexity. The molecular differences we’re trying to distinguish between are no longer a part of a simple structure but embedded within the surrounding peptide environment.
Returning to the Peptide Challenge
In Part II of this series, we approached this problem using relatively short peptide fragments following chemical derivatization. Derivatization provided enhanced UV or fluorescence detection while allowing subtle stereochemical differences within the peptide fragments to be chromatographically distinguished.
Those experiments showed that short peptide stereoisomers could be chromatographically distinguished, but they also raised another question: How much more can we increase the peptide length without making drastic changes to the method or column chemistry?
Direct analysis offers a complementary approach, and by eliminating the derivatization step, the peptide remains in its native molecular form. This can be particularly valuable when the analytical objective extends beyond simply detecting an impurity to understanding differences among structurally related peptide variants, while also maintaining compatibility with complementary LC-MS strategies such as peptide mapping, degradation profiling, and structural confirmation.
To investigate that question, we moved beyond the shorter peptide fragments examined previously and selected a seven-amino-acid model peptide: LFIEWLK2
From that parent sequence, several closely related variants were created. Three contained a single D-amino acid substitution at different positions within the sequence. Another contained exactly the same amino acids rearranged into a different sequence. Finally, two truncation products were evaluated in which either the N-terminal leucine or C-terminal lysine was removed.
Together, these variants allowed us to ask three related questions:
- What happens when only stereochemistry changes?
- What happens when only sequence changes?
- And what happens when one amino acid disappears?
When Small Changes Become Difficult Impurities
As peptides become longer, the analytical challenge becomes increasingly subtle. Closely related peptide variants may be chemically different without those differences being obvious from analytical measurements that describe the molecule more broadly.
For example, replacing an L-amino acid with its D-form does not change molecular weight or elemental composition. Within a peptide, however, that single stereochemical inversion changes the three-dimensional arrangement of the molecule3. Sequence variants present a similar challenge whereby two peptides can contain exactly the same amino acids and have the same molecular weight while arranging those amino acids in a different order.
The point here is that as peptide complexity increases, molecular similarity can begin to hide molecular identity. We encountered a related problem in Part III with isobaric amino acids. There, the question was essentially “If two molecules have the same molecular weight, how do we know which one is actually present?” Peptides can make that question considerably more complicated.
Mass spectrometry provides enormously valuable information about peptide composition and identity, but mass alone cannot always distinguish every structurally related peptide variant. Stereoisomers can share identical masses4. Truncation products may be readily recognized by mass, but determining exactly what structural change occurred requires additional information.
This isn’t a limitation unique to mass spectrometry, rather it highlights that different analytical measurements simply answer different molecular questions. Molecular weight provides one dimension of identity, composition another, while sequence, stereochemistry, and three-dimensional molecular arrangement provide still others.
For confident peptide characterization, the analytical challenge becomes finding complementary ways to interrogate those differences.
A Different Dimension of Selectivity
Chromatography provides an opportunity to do exactly that. Traditional reversed-phase peptide separations rely heavily on differences in hydrophobic interactions, while mass spectrometry distinguishes molecules according to mass-to-charge behavior. The ion-exchange recognition mechanism used by Vaast introduces a different interaction environment, where changes in stereochemistry, sequence, charge distribution, and local molecular environment can influence interaction with the stationary phase.
One mechanism isn’t inherently better than another, they simply “see” molecules differently based on the molecular properties driving the separation. For closely related peptide impurities, that difference can be particularly valuable. A molecular change that produces little or no difference in one analytical dimension may become much more apparent when examined through another.
The recent seven amino-acid study provides a useful demonstration2. Native peptide variants differing in stereochemistry, sequence arrangement, or truncation could be chromatographically differentiated using the same stationary-phase chemistry. This provides important complementarity to other analytical techniques used for peptide characterization.
Expanding the Analytical Toolbox
The latest work also extends what we learned from the peptide fragments discussed in Part II. Those earlier experiments used chemical derivatization, which remains valuable for enhancing UV or fluorescence detection, particularly when peptide impurities are present at low levels. The newer work demonstrates that closely related peptide variants can also be analyzed directly, without first modifying the molecule2.
These should not be viewed as competing approaches, as the two workflows address somewhat different analytical needs. Derivatization can provide enhanced detection and another opportunity to influence chromatographic recognition. Direct analysis preserves the native molecular composition and can integrate more naturally with complementary techniques such as LC-MS, peptide mapping, degradation profiling, and structural confirmation.
Which approach makes sense therefore depends on the analytical problem. When sensitivity is the primary challenge, derivatization may provide an important advantage. When preserving the native peptide or maintaining compatibility with complementary characterization techniques is important, direct analysis may be preferable. Difficult impurity investigations may benefit from both.
When we first explored peptide fragments in Part II, the question was whether subtle stereochemical differences could still be recognized after amino acids had been incorporated into a short peptide. Continued development has extended that work to longer native peptides and a broader range of structurally related impurities, opening new questions about how far this approach can be applied to peptide characterization.
Citations
1Li W, O’Brien-Simpson NM, Holden JA, et al. Characterization of synthetic peptide therapeutics using liquid chromatography–mass spectrometry: challenges, solutions, pitfalls, and future perspectives. J Am Soc Mass Spectrom. 2021. doi:10.1021/jasms.0c00479.
2Alvarez S, Kinderstuth L, Franco P. Expanding Peptide Analysis: Chiral and Achiral Separation of Native Peptide Variants on the Daicel Vaast Column. Daicel Chiral Technologies Application Note. 2026.
3Soyez D, Toullec J-Y, Montagné N, Ollivaux C. Experimental strategies for the analysis of D-amino acid containing peptides in crustaceans: a review. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879(29):3102–3107. doi:10.1016/j.jchromb.2011.03.032
4Jansson ET. Strategies for analysis of isomeric peptides. J Sep Sci. 2018; 41(1):385–397. doi:10.1002/jssc.201700852.
